Cancer-Specific Network Components
The identification of genetic markers (e.g. genes, pathways and subnetworks) for cancer has been one of the most challenging research areas in recent years.
A subset of these studies attempt to analyze genome-wide expression profiles to identify markers with high reliability and reusability across independent whole-transcriptome microarray datasets.
Therefore, the functional relationships of genes are integrated with their expression data. However, for (...)
Home > A. Molecular pathology > Systems medicine > Network medicine
Network medicine
Network biology
-
cancer network
8 October 2016 -
disease network topology
12 October 2015References
Biological function through network topology: a survey of the human diseasome. Janjić V, Pržulj N. Brief Funct Genomics. 2012 Nov;11(6):522-32. doi:10.1093/bfgp/els037 . PMID: #22962330# -
symptoms-disease network
12 October 2015See also
symptoms
diseases
References
Human symptoms-disease network. Zhou X, Menche J, Barabási AL, Sharma A. Nat Commun. 2014 Jun 26;5:4212. doi:10.1038/ncomms5212 . PMID: #24967666# -
network science
11 October 2015WP
Network science is an academic field which studies complex networks such as telecommunication networks, computer networks, biological networks, cognitive and semantic networks, and social networks, considering distinct elements or actors represented by nodes (or vertices) and the connections between the elements or actors as links (or edges).
The field draws on theories and methods including graph theory from mathematics, statistical mechanics from physics, data mining and (...) -
network medicine
17 April 2011References
Network medicine: a network-based approach to human disease. Barabási AL, Gulbahce N, Loscalzo J. Nat Rev Genet. 2011 Jan;12(1):56-68. PMID: #21164525# -
network analysis of cancer resequencing data
14 April 2010Large-scale tumor resequencing studies have identified a number of mutations that might be involved in tumorigenesis.
Analysis of the frequency of specific mutations across different tumors has been able to identify some, but not all of the mutated genes that contribute to tumor initiation and progression.
One reason for this is that other functionally important genes are likely to be mutated more rarely and only in specific contexts.
Thus, for example, mutation in one member of a (...) -
network analysis of allelic association data
14 April 2010network analysis of genome-wide association study (GWAS)
-
network analysis
14 April 2010Network and pathway analysis tools are traditionally used to interrogate gene expression data in order to understand the biological processes affected by a particular manipulation or disease/condition of interest.
A systems-level understanding of the biological processes affected in particular disease states can allow one to identify candidates not only for pharmaceutical intervention but also for potential prognostic and diagnostic markers for the disease.
However, network and pathway (...) -
genetic regulatory network
11 July 2008regulatory networks
References
Döhr S, Klingenhoff A, Maier H, Hrabé de Angelis M, Werner T, Schneider R. Linking disease-associated genes to regulatory networks via promoter organization. Nucleic Acids Res. 2005 Feb 8;33(3):864-72. PMID: #15701758# -
disease network
2 July 2008diseasome; human disease networks; human disease network
A network of disorders and disease genes linked by known disorder-gene associations offers a platform to explore in a single graph-theoretic framework all known phenotype and disease gene associations, indicating the common genetic origin of many diseases.
Genes associated with similar disorders show both higher likelihood of physical interactions between their products and higher expression profiling similarity for their (...)